Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephanie J. Lee
Fred Hutch/University of Washington Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vancouver General Hospital/bc Cancer
Vancouver, British Columbia, Canada
- University of Florida
Gainesville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Dana-Farber Harvard Cancer Center
Boston, Massachusetts, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
- Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
- Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jun 2020
- Primary completion
- 1 Jul 2027
- Completion
- 1 Jul 2027
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 211
- Registry id
- NCT04431479
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.